Income Statement

Currency: USD

	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016
Revenue
Interest Expense	1	1	3	0	2	3	3	5	6	6	6	6	7	7
Revenue	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A
Operating Income
Operating Expenses	(14)	(14)	(18)	(20)	(25)	(30)	(31)	(35)	(38)	(38)	(39)	(35)	(28)	(21)
Selling, General & Administrative	(4)	(5)	(8)	(10)	(12)	(12)	(11)	(12)	(11)	(11)	(11)	(11)	(10)	(9)
Research & Development	(10)	(9)	(10)	(10)	(13)	(17)	(20)	(24)	(26)	(27)	(27)	(24)	(18)	(12)
Operating Income	(14) N/A	(14) -5%	(18) -26%	(20) -13%	(25) -24%	(30) -17%	(31) -6%	(35) -13%	(38) -8%	(38) 0%	(39) -2%	(35) +9%	(28) +19%	(21) +25%
Pre-Tax Income
Interest Income Expense	(1)	(3)	(2)	(1)	(2)	(1)	(5)	(7)	(7)	(9)	6	6	5	4
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	(17)	(19)	(19)	(26)
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	(0)	(0)	(0)
Total Other Income	0	0	0	0	0	0	0	(1)	(1)	(1)	(1)	0	0	0
Pre-Tax Income	(15) N/A	(17) -16%	(20) -17%	(22) -10%	(27) -25%	(31) -12%	(36) -17%	(43) -20%	(46) -6%	(47) -3%	(50) -5%	(48) +3%	(43) +11%	(43) 0%
Net Income
Tax Provision	0	0	0	0	0	0	0	0	0	0	0	0	0	2
Income from Continuing Operations	(15)	(17)	(20)	(22)	(27)	(31)	(36)	(43)	(46)	(47)	(50)	(48)	(43)	(41)
Net Income (Common)	(18) N/A	(21) -13%	(23) -13%	(24) -5%	(29) -19%	(31) -9%	(36) -15%	(43) -20%	(46) -6%	(47) -3%	(50) -5%	(48) +3%	(43) +11%	(41) +5%
EPS (Diluted)	-0.86 N/A	-0.97 -13%	-1.1 -13%	-1.08 +2%	-1.29 -19%	-1.4 -9%	-1.61 -15%	-1.89 -17%	-1.96 -4%	-1.98 -1%	-2.1 -6%	-1.94 +8%	-1.75 +10%	-1.64 +6%

TetraLogic Pharmaceuticals Corp
OTC:TLOG